LOGIN
Blood Loss and Time to Ambulation Decreased in Lumbar Interbody Fusion Patients with TXA vs Placebo
September 2020
Blood Loss and Time to Ambulation Decreased in Lumbar Interbody Fusion Patients with TXA vs Placebo
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Tranexamic Acid for Blood Loss after Transforaminal Posterior Lumbar Interbody Fusion Surgery: A Double-Blind, Placebo-Controlled, Randomized Study.
Biomed Res Int. 2020 Aug 14;2020:8516504Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Forty patients undergoing transforaminal lumbar interbody fusion were randomized into receiving tranexamic acid or a placebo. Outcomes of interest included blood loss, postoperative drainage volume, time to drainage removal, time to ambulation, length of hospital stay, hemoglobin (Hb) levels post-operation, and the incidence of adverse events. Results demonstrated that intraoperative blood loss wa...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.